Biotronik SE & Co KG - Product Pipeline Analysis, 2023 Update

Biotronik SE & Co KG (Biotronik) is a medical device company that develops, manufactures and distributes cardiovascular and endovascular solutions. The company’s cardiac rhythm management solutions include implantable devices, leads, and accessories and external devices to treat and manage arrhythmia-related diseases. Its electrophysiology products include heart catheters used to diagnose and treat cardiac arrhythmias; and vascular intervention products such as stent systems, balloon catheters and guide wires for the treatment of peripheral, and coronary artery diseases. Biotronik has manufacturing facilities in Germany, Singapore, Switzerland, and the US. Biotronik is headquartered in Berlin, Germany.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
The report analyzes all pipeline products in development for the company Biotronik SE & Co KG
The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
The report provides detailed description of products in development, technical specification and functions
The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
To formulate effective Research & Development strategies
Develop market-entry and market expansion strategies
Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

Biotronik SE & Co KG Company Overview
Biotronik SE & Co KG Company Snapshot
Biotronik SE & Co KG Pipeline Products and Ongoing Clinical Trials Overview
Biotronik SE & Co KG - Pipeline Analysis Overview
Business Description
Biotronik SE & Co KG - Key Facts
Biotronik SE & Co KG - Major Products and Services
Biotronik SE & Co KG Pipeline Products by Development Stage
Biotronik SE & Co KG Ongoing Clinical Trials by Trial Status
Biotronik SE & Co KG Pipeline Products Overview
Allevia
Allevia Product Overview
AMS-2
AMS-2 Product Overview
Amvia Edge Pacemaker
Amvia Edge Pacemaker Product Overview
Amvia Sky DR-T Pacemaker (CRT-P)
Amvia Sky DR-T Pacemaker (CRT-P) Product Overview
Amvia Sky HF-T Pacemaker (CRT-P)
Amvia Sky HF-T Pacemaker (CRT-P) Product Overview
Amvia Sky HF-T QP Pacemaker
Amvia Sky HF-T QP Pacemaker Product Overview
Amvia Sky HF-T QP Pacemaker Clinical Trial
Amvia Sky SR-T Pacemaker (CRT-P)
Amvia Sky SR-T Pacemaker (CRT-P) Product Overview
Amvia Stellar
Amvia Stellar Product Overview
BIOVALVE Resheathable Transcatheter Aortic Valve
BIOVALVE Resheathable Transcatheter Aortic Valve Product Overview
BIOVALVE Resheathable Transcatheter Aortic Valve Clinical Trial
Cardiac Conduction System
Cardiac Conduction System Product Overview
Coronary Stent System
Coronary Stent System Product Overview
Delivr
Delivr Product Overview
DREAMS 3G System
DREAMS 3G System Product Overview
DREAMS 3G System Clinical Trial
ElePulse System
ElePulse System Product Overview
ElePulse System Clinical Trial
Hatriq
Hatriq Product Overview
Implantable Pressure Sensor
Implantable Pressure Sensor Product Overview
Magmaris Bioresorbable Magnesium Scaffold
Magmaris Bioresorbable Magnesium Scaffold Product Overview
Magmaris Bioresorbable Magnesium Scaffold Clinical Trial
Oscar Peripheral Multifunctional Catheter System
Oscar Peripheral Multifunctional Catheter System Product Overview
ProGenic Pimecrolimus-eluting Coronary Stent System
ProGenic Pimecrolimus-eluting Coronary Stent System Product Overview
Prospera Spinal Cord Stimulation (SCS) System
Prospera Spinal Cord Stimulation (SCS) System Product Overview
Prospera Spinal Cord Stimulation (SCS) System Clinical Trial
Renamic Neo Programmer
Renamic Neo Programmer Product Overview
Solvia Rise
Solvia Rise Product Overview
Solvia Rise Clinical Trial
Truelock
Truelock Product Overview
Truvia
Truvia Product Overview
Biotronik SE & Co KG - Key Competitors
Biotronik SE & Co KG - Key Employees
Biotronik SE & Co KG - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Biotronik SE & Co KG, Recent Developments
Jun 21, 2023: Philips and BIOTRONIK expand care for out-of-hospital cardiology labs with new strategic alliance
Aug 18, 2021: Latest study shows new algorithm can predict heart failure hospitalizations
Aug 05, 2021: BIOTRONIK Partners with EU-Funded SIMCor to pioneer heart and blood vessel simulation
Jun 17, 2021: Study results show stylet-driven leads can be used for LBBAP
Apr 21, 2021: Biotronik: New conduction system pacing tools for added flexibility during implantation
Apr 20, 2021: Biotronik: Experts Make the Case for Improved Patient Care in Single-Chamber ICD and CRT-D Therapy with Pioneering DX Technology
Sep 17, 2020: CIRSE 2020: New clinical data support use of 4-french devices for ambulatory pad treatment
Jun 16, 2020: Giving physicians more choices to pace in the his-bundle
May 13, 2020: Home monitoring shown to safely and efficiently replace face-to-face follow-ups for pacemaker patients
Feb 24, 2020: BIOTRONIK's Ultrathin Strut Orsiro Coronary Drug-Eluting Stent continues to deliver excellent results after three years
Appendix
Methodology
About the Publisher
Contact the Publisher
Disclaimer

List of Tables

Biotronik SE & Co KG Pipeline Products and Ongoing Clinical Trials Overview
Biotronik SE & Co KG Pipeline Products by Equipment Type
Biotronik SE & Co KG Pipeline Products by Indication
Biotronik SE & Co KG Ongoing Clinical Trials by Trial Status
Biotronik SE & Co KG, Key Facts
Biotronik SE & Co KG, Major Products and Services
Biotronik SE & Co KG Number of Pipeline Products by Development Stage
Biotronik SE & Co KG Pipeline Products Summary by Development Stage
Biotronik SE & Co KG Ongoing Clinical Trials by Trial Status
Biotronik SE & Co KG Ongoing Clinical Trials Summary
Allevia - Product Status
Allevia - Product Description
AMS-2 - Product Status
AMS-2 - Product Description
Amvia Edge Pacemaker - Product Status
Amvia Edge Pacemaker - Product Description
Amvia Sky DR-T Pacemaker (CRT-P) - Product Status
Amvia Sky DR-T Pacemaker (CRT-P) - Product Description
Amvia Sky HF-T Pacemaker (CRT-P) - Product Status
Amvia Sky HF-T Pacemaker (CRT-P) - Product Description
Amvia Sky HF-T QP Pacemaker - Product Status
Amvia Sky HF-T QP Pacemaker - Product Description
Amvia Sky HF-T QP Pacemaker - BIO|CONCEPT.Amvia, First in Human Study for the Amvia/Solvia Pacemaker Family
Amvia Sky SR-T Pacemaker (CRT-P) - Product Status
Amvia Sky SR-T Pacemaker (CRT-P) - Product Description
Amvia Stellar - Product Status
Amvia Stellar - Product Description
BIOVALVE Resheathable Transcatheter Aortic Valve - Product Status
BIOVALVE Resheathable Transcatheter Aortic Valve - Product Description
BIOVALVE Resheathable Transcatheter Aortic Valve - Safety and Clinical Performance of the Self-expanding Transcatheter BIOVALVE Prosthesis in Subjects with Severe Symptomatic Aortic Stenosis Suitable for Transfemoral Transcatheter Aortic Valve Implantation
Cardiac Conduction System - Product Status
Cardiac Conduction System - Product Description
Coronary Stent System - Product Status
Coronary Stent System - Product Description
Delivr - Product Status
Delivr - Product Description
DREAMS 3G System - Product Status
DREAMS 3G System - Product Description
DREAMS 3G System - BIOTRONIK - Safety and Clinical Performance of the - Sirolimus-Eluting Resorbable Coronary Magnesium Scaffold System (DREAMS 3G) in the Treatment of Subjects with de Novo Lesions in Native Coronary Arteries
DREAMS 3G System - BIOTRONIK-Safety and Clinical Performance of the Drug Eluting Resorbable Coronary MAGnesium Scaffold System (DREAMS 3G) in the Treatment of Subjects With de Novo Lesions in Native Coronary Arteries: BIOMAG-II: A Randomized Controlled Trial
ElePulse System - Product Status
ElePulse System - Product Description
ElePulse System - Rapid One-Shot Electroporation Trial For Atrial Fibrillation: Reset-AF: Investigating the Effect of A Novel Intervention on Atrial Fibrillation Recurrence
Hatriq - Product Status
Hatriq - Product Description
Implantable Pressure Sensor - Product Status
Implantable Pressure Sensor - Product Description
Magmaris Bioresorbable Magnesium Scaffold - Product Status
Magmaris Bioresorbable Magnesium Scaffold - Product Description
Magmaris Bioresorbable Magnesium Scaffold - A Sirolimus Eluting Bioresorbable Magnesium Stent for Treatment of Coronary Bifurcation Lesions: The BIFSORB Pilot Study II
Magmaris Bioresorbable Magnesium Scaffold - BIOTRONIK - Safety and Clinical Performance of the Drug Eluting Absorbable Metal Scaffold (DREAMS 2nd Generation) in the Treatment of Subjects with de Novo Lesions in Native Coronary Arteries: BIOSOLVE-II
Magmaris Bioresorbable Magnesium Scaffold - Biotroniks - Safety and Performance in de Novo Lesion of Native Coronary Arteries with Magmaris- Registry: BIOSOLVE-IV
Magmaris Bioresorbable Magnesium Scaffold - Coronary Artery Healing Process after Bioresorbable Scaffold in Patients with Non-ST-segment Elevation Myocardial Infarction (NSTEMI)
Magmaris Bioresorbable Magnesium Scaffold - Optical Coherence Guided Treatment of ST-segment Elevation Myocardial Infarction with the Drug-eluting Resorbable Magnesium Scaffold: The BEST- MAG Multicentre Study (Belgian ST-segment Elevation Myocardial Infarction Treatment with Resorbable Magnesium Scaffold)
Magmaris Bioresorbable Magnesium Scaffold -